天然产物研究与开发 ›› 2024, Vol. 36 ›› Issue (3): 528-539.doi: 10.16333/j.1001-6880.2024.3.016

• 数据研究 • 上一篇    下一篇

基于体外细胞实验和网络药理学探讨槐定碱治疗前列腺癌的作用机制

王   乐,芦春斌*   

  1. 暨南大学生命科学技术学院,广州 510632
  • 出版日期:2024-03-20 发布日期:2024-03-20
  • 基金资助:
    广东省林业科技创新项目(2021KJCX013)

Molecular mechanism of sophoridine in the treatment of prostate cancer based on cell experiments in vitro and network pharmacology

WANG Le,LU Chun-bin*   

  1. College of Life Science and Technologies,Jinan University,Guangzhou 510632,China
  • Online:2024-03-20 Published:2024-03-20

摘要:

基于体外细胞实验、网络药理学和分子对接探讨槐定碱(sophoridine,SRI)对DU-145前列腺癌细胞增殖、凋亡的影响及其作用机制。MTT、克隆形成以及免疫荧光实验检测SRI对DU-145细胞增殖的影响,流式细胞术检测细胞凋亡情况。qPCR检测Ki67、PCNA、Caspase-3/7、Bcl-2、Bax以及p38MAPK mRNA表达。Western blot检测PCNA、Caspase-3、Bcl-2、Bax、p38MAPK以及p-p38MAPK蛋白表达。利用TCMSP、HERB、Swiss Target Prediction和PharmMapper数据库获得SRI靶点,利用OMIM、GeneCards数据库收集前列腺癌靶点,并通过Venny2.1.0筛选两者的共同靶点。利用STRING数据库构建蛋白-蛋白互作(protein-protein interaction,PPI)网络,采用Cytoscape3.9.0软件进行网络拓扑学分析以及PPI网络可视化。通过DAVID数据库进行GO富集和KEGG通路分析。采用AutoDock1.5.6软件进行分子对接。细胞实验结果表明SRI能显著抑制DU-145细胞的增殖,并促进其凋亡。PPI网络分析得到ALB、MAPK1、CASP3、MAPK8、p38MAPK等16个核心靶点。GO富集分析得到158个条目(< 0.01),主要集中在细胞凋亡过程、蛋白质磷酸化、蛋白丝氨酸/苏氨酸/酪氨酸激酶活性等。KEGG富集分析得到84个信号通路(< 0.01),涉及癌症通路、癌症中的蛋白多糖、MAPK信号通路等。分子对接结果表明SRI与核心靶点p38MAPK能够稳定结合。qPCR和Western blot结果证实SRI能促进p38MAPK的表达。综上,本研究表明SRI能抑制DU-145前列腺癌细胞的增殖并促进其凋亡,这可能与p38MAPK的激活有关。

关键词: 前列腺癌, 槐定碱, 增殖, 凋亡, p38MAPK

Abstract:

The effect of Sophoridine (SRI) on the proliferation and apoptosis of DU-145 prostate cancer cells,as well as its mechanism of action were investigated based on cell experiments in vitro,network pharmacology and molecular docking.MTT,colony formation,and immunofluorescence assays were used to detect the effects of SRI on DU-145 cell proliferation,and flow cytometry was used to detect cell apoptosis.qPCR was used to detect the mRNA expression of Ki67,PCNA,Caspase-3/7,Bcl-2,Bax and p38MAPK.The protein expression of PCNA,Caspase-3,Bcl-2,Bax,p38MAPK and p-p38MAPK were detected by Western blot.Several databases,including TCMSP,HERB,Swiss Target Prediction,and PharmMapper were utilized to obtain SRI targets and the OMIM and GeneCards databases were used to collect prostate cancer targets.Common targets between the two datasets were screened using Venny2.1.0.The STRING database was used to construct a protein-protein interaction (PPI) network,and network topology analysis and PPI network visualization were performed using Cytoscape3.9.0 software.GO enrichment and KEGG pathway analysis were performed by DAVID database.Molecular docking was performed using AutoDock1.5.6 software.The results of cell experiments showed that SRI significantly inhibited DU-145 cell proliferation and promoted apoptosis.The PPI network analysis revealed 16 core targets including ALB,MAPK1,CASP3,MAPK8,and p38MAPK.The GO enrichment analysis yielded 158 entries (P < 0.01),were mainly concentrated in apoptosis process,protein phosphorylation,and protein serine/threonine/tyrosine kinase activity.KEGG enrichment analysis obtained 84 signaling pathways(P< 0.01),involving cancer pathways,proteoglycans in cancer,MAPK signaling pathway and other signaling pathways.Molecular docking results showed that SRI can stably bind to the core target p38MAPK.qPCR and Western blot results confirmed that SRI can promote the expression of p38MAPK.In conclusion,this study shows that SRI can inhibit the proliferation and promote apoptosis of DU-145 prostate cancer cells,which may be associated with p38MAPK activation.

Key words: prostate cancer, sophoridine, proliferation, apoptosis, p38MAPK

中图分类号:  R285.5